Key result
The COVID-19 pandemic was associated with an estimated 40% reduction in STEMI admissions, significant delays in treatment, and a threefold increase in in-hospital mortality for STEMI patients with COVID-19.
Why the study?
Diseases requiring time-sensitive treatment, such as STEMI, faced significant challenges due to the impact of the COVID-19 pandemic on healthcare infrastructure.
The COVID-19 pandemic significantly disrupted STEMI care globally, leading to decreased hospitalizations, delayed treatments, and higher mortality rates, particularly in patients with concurrent COVID-19 infection.
Warrants contingency planning to preserve timely STEMI care in future crises; leaves open optimal mitigation strategies for prospective evaluation.
The global repercussions of coronavirus disease 2019 (COVID-19) include substantial worldwide mortality and have brought to light existing gaps in healthcare systems. Particularly, diseases requiring time-sensitive treatment, such as ST-elevation myocardial infarction (STEMI), have faced significant challenges due to the impact and revelations of the COVID-19 pandemic on healthcare infrastructure. This review addresses the impact of the pandemic on STEMI, exploring incidence, treatment modalities, and clinical outcomes. Through a critical examination of existing literature, the intricate relationship between the pandemic and cardiovascular health, specifically STEMI, is elucidated. The COVID-19 pandemic has had a significant impact on the management of STEMI, with changes in hospitalization rates, treatment strategies, and the presentation of the disease posing significant challenges. The contradictory results of COVID-19 and post-vaccine myocardial infarction, as well as gender differences in reported cases, highlight the need for further research to clarify these relationships.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2024) conducted a review in ST-Elevation Myocardial Infarction (STEMI). COVID-19 pandemic vs. Pre-pandemic period was evaluated on Incidence, treatment modalities, and clinical outcomes of STEMI. The COVID-19 pandemic was associated with an estimated 40% reduction in STEMI admissions, significant delays in treatment, and a threefold increase in in-hospital mortality for STEMI patients with COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: